phase readout

NCT02942290: A Study Evaluating Venetoclax in Combination With Azacitidine in Participants With Treatment-Naïve Higher-Risk Myelodysplastic Syndromes (MDS)

ACTIVE_NOT_RECRUITINGupdated 1mo ago

community read0 votes

Sponsor: AbbVie. Phase: PHASE1. Conditions: Myelodysplastic Syndromes (MDS)

Data sources

last refreshed 2h ago

Found something off?

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?